Danbury, CT, United States of America

Jonathan Emillian Emeigh


Average Co-Inventor Count = 10.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Gilbertsville, PA (US) (2005)
  • Danbury, CT (US) (2005 - 2009)

Company Filing History:


Years Active: 2005-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Emillian Emeigh

Introduction

Jonathan Emillian Emeigh is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. With a total of 4 patents to his name, Emeigh's work focuses on developing small molecules that can effectively combat various health conditions.

Latest Patents

Emeigh's latest patents include groundbreaking compounds that are useful in treating or preventing inflammatory and immune cell-mediated diseases. One of his notable inventions is a series of substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds. These compounds are designed to inhibit the kinase activity of the IκB kinase (IKK) complex, which plays a crucial role in various diseases, including autoimmune disorders, inflammatory diseases, and cancer. Additionally, he has disclosed pharmaceutical compositions that incorporate these compounds, along with processes for their preparation.

Career Highlights

Emeigh is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Some of Emeigh's notable coworkers include Ronald John Sorcek and Jiang-Ping Wu. Their collaborative efforts have further advanced the research and development of effective treatments in the pharmaceutical field.

Conclusion

Jonathan Emillian Emeigh is a distinguished inventor whose work in developing small molecules for treating inflammatory diseases has made a significant impact. His contributions to the pharmaceutical industry continue to pave the way for innovative treatments that enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…